COMMUNIQUÉS West-GlobeNewswire

SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States
17/06/2024
Further Advances SIGA’s Strategy to Expand Access to TPOXX into More International Markets NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on global [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
17/06/2024
BRISBANE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating [...]
Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company
17/06/2024
Company filed an answer in overall agreement with petition on June 14, 2024 and awaits a hearing date from the Delaware Chancery Court BOULDER, Colo., June 17, 2024 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. ( [...]
Celon Pharma Announces Results of Phase II clinical trial for CPL’ 116, a JAK/ROCK dual inhibitor in the treatment of Rheumatoid Arthritis (RA)
17/06/2024
KIELPIN, Poland, June 17, 2024 (GLOBE NEWSWIRE) -- Celon Pharma S.A. (CLN.WA) today announced the successful completion of a Phase 2 trial a JAK/ROCK dual inhibitor in the treatment of Rheumatoid Arthritis (RA). The [...]
Vaxart Provides Business Update
17/06/2024
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones [...]
PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy
17/06/2024
SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
Keros Therapeutics Announces Leadership Updates
17/06/2024
LEXINGTON, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization [...]
Ezra Launches Partnership with AMRIC Health to Enable Whole-Body MRI Screenings in New York Clinics
17/06/2024
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Ezra , the healthcare AI startup transforming early cancer detection through full body MRI screening, today launched a new partnership with AMRIC Health , a precision imaging [...]
AAPS Calls for Elimination of ‘Diversity, Equity, and Inclusion’ Ideology from Medicine
17/06/2024
TUCSON, Ariz., June 17, 2024 (GLOBE NEWSWIRE) -- In a statement adopted on June 17, the Association of American Physicians and Surgeons calls for “urgent actions … to eliminate the destructive ‘diversity, equity, and [...]
The era of biosolutions. Outlook upgraded for 2024
17/06/2024
Novonesis is performing very well and the 2024 outlook for pro forma organic sales growth is now expected at the upper end of the 5-7% range while the pro forma adjusted EBITDA margin is increased to 35-36%. Novonesis’ [...]
BioPorto A/S initiates a private placement of 50,000,000 new shares at market price.
17/06/2024
June 17, 2024 Announcement no. 13 THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER [...]
EchoNous Announces Sale of 157 Units of Kosmos Ultrasound Technology to Madrid’s Primary Care System
17/06/2024
MADRID, June 17, 2024 (GLOBE NEWSWIRE) -- EchoNous, a leader in AI-enabled point-of-care ultrasound systems (POCUS), is excited to announce the installation of 157 Kosmos units in more than 150 primary care centers [...]
TALVEY®▼ (talquetamab) a permis d’obtenir des réponses très durables et à plus long terme chez des patients atteints de myélome multiple récidivant ou réfractaire
17/06/2024
Taux de survie globale à 24 mois de 67 pour cent obtenu avec le talquetamab administré à raison de 0,8 mg/kg toutes les deux semaines dans l’étude de la Phase 1/2 MonumenTAL-11 1 BEERSE, BELGIQUE, 17 juin 2024 (GLOBE [...]
Les résultats issus de l’étude RESONATE-2 de référence confirment le bénéfice durable en matière de survie d’IMBRUVICA® (ibrutinib) dans le traitement de première intention de la leucémie lymphoïde chronique avec une durée de suivi allant jusqu’à 10 ans
17/06/2024
Les données issues de RESONATE-2 présentées au congrès 2024 de l’European Hematology Association (EHA) fournissent des résultats et des données de sécurité à plus long terme que ceux jamais rapportés pour un inhibiteur [...]
Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
17/06/2024
First regulatory submission completed for CHIKV VLP seeking approval of the vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older Represents first BLA for a [...]
EchoNous Announces Sale of 157 Units of Kosmos Ultrasound Technology to Madrid’s Primary Care System
17/06/2024
MADRID, Spain, June 17, 2024 (GLOBE NEWSWIRE) -- EchoNous, a leader in AI-enabled point-of-care ultrasound systems (POCUS), is excited to announce the installation of 157 Kosmos units in more than 150 primary care [...]
Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation
17/06/2024
HOUSTON, June 17, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar [...]
Immix Biopharma to Present at the Stifel 2024 Cell Therapy Forum
17/06/2024
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today [...]
Transactions in Connection with Share Buy-back Program
17/06/2024
Company Announcement COPENHAGEN, Denmark; June 17, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. [...]

Pages